Trials / Recruiting
RecruitingNCT06491056
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
Prospective Multicenter Asian Observational Study of Oncological and Functional Outcomes After Focal Therapy of Prostate Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Singapore General Hospital · Academic / Other
- Sex
- Male
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia
Detailed description
Patients undergoing Focal Cryotherapy, Focal HIFU, Focal IRE, Focal Laser ablation, or other partial gland ablation modalities for prostate cancer will be recruited.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Focal Therapy for Prostate Cancer | Ablation of \<75% of the prostate gland for limited volume prostate cancer |
Timeline
- Start date
- 2023-05-06
- Primary completion
- 2028-05-06
- Completion
- 2048-05-06
- First posted
- 2024-07-08
- Last updated
- 2024-07-08
Locations
1 site across 1 country: Singapore
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06491056. Inclusion in this directory is not an endorsement.